2020
DOI: 10.15586/jptcp.v27i2.663
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic effect of inhaled budesonide in transient tachypnea of newborn: A placebo-controlled study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…For example, inhaled budesonide has been widely used in neonatal respiratory distress syndrome, but no obvious adverse reactions have been registered. 20 , 21 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, inhaled budesonide has been widely used in neonatal respiratory distress syndrome, but no obvious adverse reactions have been registered. 20 , 21 …”
Section: Discussionmentioning
confidence: 99%
“…For example, inhaled budesonide has been widely used in neonatal respiratory distress syndrome, but no obvious adverse reactions have been registered. 20,21 Zhang et al found that hematologic malignancies and previous cephalosporin administration were associated with the development of CRKP BSI, while mechanical ventilation, septic shock, and CRKP infection were independent mortality predictors for K. pneumoniae associated BSI (Zhang Y et al 2018). 12 Bor M et al found that previous antifungal use, congenital anomalies, and TPN use were found to be independent risk factors for mortality in neonates with CRKP infection.…”
mentioning
confidence: 99%
“…Celebi et al 14) have suggested that the prophylactic use of positive pressure ventila tion in the delivery room reduced NICU admission rates. If respi ratory support such as oxygen via a nasal cannula or mechanical ventilation is not provided during an acute illness, respira tory failure may occur because of fatigue and exhaustion of the res piratory muscles 15) . All neonates received supplemental oxy gen therapy to maintain oxygen saturation (≥90%) during hospitali zation.…”
Section: Discussionmentioning
confidence: 99%